Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02425495

Ligand	Ligand name	Chain	PDB	Tanimoto
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.73
CA4	CYPROTERONE ACETATE	A	2OZ7	0.7
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A	2RKV	0.71
ZBA	12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol-4,15-diacetate-8-isovalerate	A,B,C,D	2ZBA	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.89
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.89
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.89
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.73
0AS	asiatic acid	A	2QN1	0.73
VDZ	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RJK	0.71
MVD	2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3	A	2HB8	0.71
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.79
COV	(1S,3R,5Z,7E,14beta,17alpha)-17-[(2S,4S)-4-(2-hydroxy-2-methylpropyl)-2-methyltetrahydrofuran-2-yl]-9,10-secoandrosta-5,7,10-triene-1,3-diol	A	3CS4	0.72
2OB	CHOLESTERYL OLEATE	A	2OBD	0.81
GA3	GIBBERELLIN A3	A	2ZSH	0.73
GA3	GIBBERELLIN A3	A,B,C,D,E,F	3ED1	0.73
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.87
DOG	DIGOXIGENIN	A	1LKE	0.82
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.77
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.77
PRB	13-ACETYLPHORBOL	A	1PTR	0.76
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.81
C33	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAM	0.71
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.77
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.77
C0R	CORTICOSTERONE	A	2A3I	0.79
C0R	CORTICOSTERONE	A,B	1Y5R	0.79
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.81
AS4	ALDOSTERONE	A	2AA2	0.78
AS4	ALDOSTERONE	A	2Q1H	0.78
0MA	maslinic acid	A	2QN2	0.73
WIN	methyl (5beta,7alpha,9beta,10alpha,11alpha,12alpha,13beta,15alpha)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-3,11,12-trihydroxy-2,16-dioxo-13,20-epoxypicras-3-en-21-oate	0,1,2,3,9,A,B,C,F,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	3G71	0.75
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	A,D	1R1K	0.88
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,U	1Z5X	0.88
P1A	2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE	E,F,G,H	2NXX	0.88
17H	17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE	A	2AMB	0.72
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.71
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.8
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZBZ	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RK3	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1DB1	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE9	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2HC4	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZLC	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	3CV9	0.71
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EAU	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB3	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	3EB4	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	2AAX	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	1H61	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A,B	3CMF	0.81
PDN	17,21-DIHYDROXYPREGNA-1,4-DIENE-3,11,20-TRIONE	A	2Q1V	0.81
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.82
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.82
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.82
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.79
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.79
DGX	DIGOXIN	B,D	1IGJ	0.7
DTX	DIGITOXIGENIN	A	1LNM	0.82
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.79
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.72
GR4		H,I	1AWF	0.76
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1E3G	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A,B	1E3K	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	2AO6	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XOW	0.72
R18	(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE	A	1XQ3	0.72
PID	PERIDININ	A	2C9E	0.7
PID	PERIDININ	M,N,O	1PPR	0.7
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.71
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.72
S5H	5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE	L	2DBL	0.71
ZK5	9ALPHA-FLUOROCORTISOL	A	1GS4	0.77
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.82
B2S	(3alpha,7alpha)-3,7,15-trihydroxy-12,13-epoxytrichothec-9-en-8-one	A	3B2S	0.7
0CO	(1S,3R,5Z,7E,14beta,17alpha,23R)-23-(2-hydroxy-2-methylpropyl)-20,24-epoxy-9,10-secochola-5,7,10-triene-1,3-diol	A	3CS6	0.72
DEX	DEXAMETHASONE	A,D	1M2Z	0.75
DEX	DEXAMETHASONE	A,B,C,D	1P93	0.75
FUA	FUSIDIC ACID	A	1QCA	0.87
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.87
FUA	FUSIDIC ACID	A,B	2VUF	0.87
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.79
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.79
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.79
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.79
CLR	CHOLESTEROL	A,B	2ZXE	0.71
CLR	CHOLESTEROL	A	1N83	0.71
CLR	CHOLESTEROL	A	2RH1	0.71
CLR	CHOLESTEROL	A	1LRI	0.71
CLR	CHOLESTEROL	A	1ZHY	0.71
CLR	CHOLESTEROL	A	3D4S	0.71
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.73
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.73
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.73
TES	TESTOSTERONE	A	1JTV	0.82
TES	TESTOSTERONE	A	2Q7L	0.82
TES	TESTOSTERONE	A	2Q7I	0.82
TES	TESTOSTERONE	A,B	1J96	0.82
TES	TESTOSTERONE	A	2Q7K	0.82
TES	TESTOSTERONE	A,B	1Q13	0.82
TES	TESTOSTERONE	H	1I9J	0.82
TES	TESTOSTERONE	A,B	1AFS	0.82
TES	TESTOSTERONE	H	1VPO	0.82
TES	TESTOSTERONE	A	2Q7J	0.82
TES	TESTOSTERONE	A,B	3BUR	0.82
TES	TESTOSTERONE	A	2AM9	0.82
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.71
114	COMPACTIN	A,B,C,D	1HW8	0.71
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.81
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.81
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.7
SXN	Salinixanthin	A,B	3DDL	0.72
BIV	21-NOR-9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY-4-METHYLPENTYL)-, (1A,3B,5Z,7E)	A	2HCD	0.71
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.83
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.88
OBN	OUABAIN	H,L	1IBG	0.73
SNL	SPIRONOLACTONE	A,B	2AB2	0.76
SNL	SPIRONOLACTONE	A,B,C,D,E,F	2OAX	0.76
20E	(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one	A,D	2R40	0.88
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.75